42 related articles for article (PubMed ID: 4948080)
1. Rapid, radiolabeled macrophage culture method for detection of dapsone-resistant Mycobacterium leprae.
Nath I; Prasad HK; Sathish M; Sreevatsa ; Desikan KV; Seshadri PS; Iyer CG
Antimicrob Agents Chemother; 1982 Jan; 21(1):26-32. PubMed ID: 7044299
[TBL] [Abstract][Full Text] [Related]
2. Rapid in vitro metabolic screen for antileprosy compounds.
Franzblau SG; Hastings RC
Antimicrob Agents Chemother; 1987 May; 31(5):780-3. PubMed ID: 3300539
[TBL] [Abstract][Full Text] [Related]
3. Biophysical optima for metabolism of Mycobacterium leprae.
Franzblau SG; Harris EB
J Clin Microbiol; 1988 Jun; 26(6):1124-9. PubMed ID: 3290244
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.
Franzblau SG
Antimicrob Agents Chemother; 1991 Jun; 35(6):1232-4. PubMed ID: 1929269
[TBL] [Abstract][Full Text] [Related]
5. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
Peters JH; Gordon GR; Murray JF; Fieldsteel AH; Levy L
Antimicrob Agents Chemother; 1975 Nov; 8(5):551-7. PubMed ID: 1108776
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of thymectomized and irradiated mice to challenge with several organisms and the effect of dapsone on infection with Mycobacterium leprae.
Levy L; Ng H; Evans MJ; Krahenbuhl JL
Infect Immun; 1975 May; 11(5):1122-32. PubMed ID: 804443
[TBL] [Abstract][Full Text] [Related]
7. Electrophoretic patterns of serum proteins and immunoglobulin levels in mycobacterial infections--studies in mice infected with mycobacterium leprae and mycobacterium lepraemurium.
Navalkar RG; Patel PJ; Dalvi RR; Kanchana MV
J Natl Med Assoc; 1976 Nov; 68(6):500-5, 524. PubMed ID: 796470
[No Abstract] [Full Text] [Related]
8. Neonatally thymectomized Lewis rats infected with Mycobacterium leprae: response to primary infection, secondary challenge, and large inocula.
Fieldsteel AH; Levy L
Infect Immun; 1976 Sep; 14(3):736-41. PubMed ID: 786892
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.
Levy L; Peters JH
Antimicrob Agents Chemother; 1976 Jan; 9(1):102-12. PubMed ID: 769667
[TBL] [Abstract][Full Text] [Related]
10. An ultrastructural study of neuromuscular spindles in normal mice: with reference to mice and man infected with Mycobacterium leprae.
Edwards RP
J Anat; 1975 Sep; 120(Pt 1):149-68. PubMed ID: 126981
[TBL] [Abstract][Full Text] [Related]
11. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Freerksen E; Rosenfeld M
Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
[No Abstract] [Full Text] [Related]
12. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
13. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
[No Abstract] [Full Text] [Related]
14. A survey of the drugs with activity against M. leprae in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080
[No Abstract] [Full Text] [Related]
15. Antileprosy drugs.
Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
[No Abstract] [Full Text] [Related]
16. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
Pattyn SR
Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
